![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, November 08, 2013 9:44:49 PM
With the injunction lifted, Shasta and Decision Diagnostics are set to "fully implement its rollout strategy for GenStrip," the companies said. With a new line of credit and its legal win in hand, Decision Diagnostics estimates that it could begin bagging annual revenues of more than $250 million.
The could be a major blow to LifeScan's business model, which relies for revenue more on sales of the strips than on the OneTouch meters themselves....
Decision Diagnostics says its strips cost up to 50% less than rival strips, and its management says it's confident that it can capture market share.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM